Literature DB >> 26373860

Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.

Tatsuo Inoue1, Tomoko Hyodo2, Keiko Korenaga3,4, Takamichi Murakami2, Yasuharu Imai5, Atsushi Higaki3, Takeshi Suda6, Toru Takano7, Kennichi Miyoshi8, Masahiko Koda8, Hironori Tanaka9,10, Hiroko Iijima9, Hironori Ochi11, Masashi Hirooka11, Kazushi Numata12, Masatoshi Kudo13.   

Abstract

BACKGROUND: It remains unknown whether Kupffer-phase images in Sonazoid-enhanced ultrasonography (US) can be used to predict hypervascularization of borderline lesions. Therefore, we aimed to clarify whether Kupffer-phase images in Sonazoid-enhanced ultrasonography can predict subsequent hypervascularization in hypovascular borderline lesions detected on hepatobiliary-phase gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging.
METHODS: From January 2008 to March 2012, 616 low-intensity hypovascular nodules were detected in hepatobiliary-phase images of Gd-EOB-DTPA-enhanced MRI at nine institutions. Among these, 167 nodules, which were confirmed as hypovascular by Gd-EOB-DTPA-enhanced MRI and Sonazoid-enhanced US, were evaluated in this study. Potential hypervascularization factors were selected based on their clinical significance and the results of previous reports. The Kaplan-Meier model and log-rank test were used for univariate analysis and the Cox regression model was used for multivariate analysis.
RESULTS: The cumulative incidence of hypervascularization of borderline lesions was 18, 37, and 43 % at 1, 2, and 3 years, respectively. Univariate analyses showed that tumor size (p = 0.0012) and hypoperfusion on Kupffer-phase images in Sonazoid-enhanced US (p = 0.004) were associated with hypervascularization of the tumor. Multivariate analysis showed that tumor size [HR: 1.086, 95 % confidence interval = 1.027-1.148, p = 0.004] and hypo perfusion on Kupffer-phase images [HR: 3.684, 95 % confidence interval = 1.798-7.546, p = 0.0004] were significantly different.
CONCLUSIONS: Kupffer-phase images in Sonazoid-enhanced US and tumor diameter can predict hypervascularization of hypointense borderline lesions detected on hepatobiliary-phase Gd-EOB-DTPA-enhanced MRI.

Entities:  

Keywords:  Gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid-enhanced MRI; Hepatocellular carcinoma; Hypervascular transformation; Kupffer phase; Sonazoid-enhanced ultrasonography

Mesh:

Substances:

Year:  2015        PMID: 26373860     DOI: 10.1007/s00535-015-1094-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  37 in total

1.  Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial.

Authors:  Fuminori Moriyasu; Kouichi Itoh
Journal:  AJR Am J Roentgenol       Date:  2009-07       Impact factor: 3.959

2.  Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma.

Authors:  Masatoshi Kudo; Kinuyo Hatanaka; Takashi Kumada; Hidenori Toyoda; Toshifumi Tada
Journal:  Am J Gastroenterol       Date:  2011-02       Impact factor: 10.864

3.  Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver.

Authors:  L Bouwens; M Baekeland; R De Zanger; E Wisse
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

4.  Cox regression analysis of multivariate failure time data: the marginal approach.

Authors:  D Y Lin
Journal:  Stat Med       Date:  1994-11-15       Impact factor: 2.373

5.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

6.  Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.

Authors:  Tatsuo Inoue; Masatoshi Kudo; Mina Komuta; Sosuke Hayaishi; Taisuke Ueda; Masahiro Takita; Satoshi Kitai; Kinuyo Hatanaka; Norihisa Yada; Satoru Hagiwara; Hobyung Chung; Toshiharu Sakurai; Kazuomi Ueshima; Michiie Sakamoto; Osamu Maenishi; Tomoko Hyodo; Masahiro Okada; Seishi Kumano; Takamichi Murakami
Journal:  J Gastroenterol       Date:  2012-04-17       Impact factor: 7.527

7.  Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.

Authors:  Sachiyo Kogita; Yasuharu Imai; Masahiro Okada; Tonsok Kim; Hiromitsu Onishi; Manabu Takamura; Kazuto Fukuda; Takumi Igura; Yoshiyuki Sawai; Osakuni Morimoto; Masatoshi Hori; Hiroaki Nagano; Kenichi Wakasa; Norio Hayashi; Takamichi Murakami
Journal:  Eur Radiol       Date:  2010-05-19       Impact factor: 5.315

8.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

9.  Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors.

Authors:  Tatsuo Inoue; Tomoko Hyodo; Takamichi Murakami; Yukihisa Takayama; Akihiro Nishie; Atsushi Higaki; Keiko Korenaga; Azusa Sakamoto; Yukio Osaki; Hiroshi Aikata; Kazuaki Chayama; Takeshi Suda; Toru Takano; Kennichi Miyoshi; Masahiko Koda; Kazushi Numata; Hironori Tanaka; Hiroko Iijima; Hironori Ochi; Masashi Hirooka; Yasuharu Imai; Masatoshi Kudo
Journal:  Dig Dis       Date:  2013-11-21       Impact factor: 2.404

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  10 in total

1.  Breakthrough Imaging in Hepatocellular Carcinoma.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-12-18       Impact factor: 11.740

2.  Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-12-15       Impact factor: 11.740

3.  Letter to the editor on "Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis".

Authors:  Jiangfeng Wu; Lijing Ge; Lili Lu
Journal:  Abdom Radiol (NY)       Date:  2021-11-08

4.  Ruptured focal nodular hyperplasia observed during follow-up: a case report.

Authors:  Masahiko Kinoshita; Shigekazu Takemura; Shogo Tanaka; Genya Hamano; Tokuji Ito; Takanori Aota; Masaki Koda; Masahiko Ohsawa; Shoji Kubo
Journal:  Surg Case Rep       Date:  2017-03-17

5.  Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm.

Authors:  Min Sun; Liqing Kang; Yanchao Cui; Guoce Li
Journal:  Exp Ther Med       Date:  2018-06-22       Impact factor: 2.447

6.  Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma.

Authors:  Feiqian Wang; Kazushi Numata; Masahiro Okada; Makoto Chuma; Hiromi Nihonmatsu; Satoshi Moriya; Akito Nozaki; Katsuaki Ogushi; Wen Luo; Litao Ruan; Masayuki Nakano; Masako Otani; Yoshiaki Inayama; Shin Maeda
Journal:  Quant Imaging Med Surg       Date:  2021-06

7.  Imaging Monitoring of Kupffer Cell Function and Hepatic Oxygen Saturation in Preneoplastic Changes During Cholangiocarcinogenesis.

Authors:  Seunghyun Lee; Jung Hoon Kim; Jeong Hwa Lee; Yoh Zen; Joon Koo Han
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

Review 8.  Current role of ultrasound in the diagnosis of hepatocellular carcinoma.

Authors:  Hironori Tanaka
Journal:  J Med Ultrason (2001)       Date:  2020-03-13       Impact factor: 1.314

9.  Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma.

Authors:  Akihiro Funaoka; Kazushi Numata; Atsuya Takeda; Yusuke Saigusa; Yuichirou Tsurugai; Hiromi Nihonmatsu; Makoto Chuma; Hiroyuki Fukuda; Masahiro Okada; Masayuki Nakano; Shin Maeda
Journal:  Diagnostics (Basel)       Date:  2021-03-09

10.  Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesions.

Authors:  Ke Lv; Hongyan Zhai; Yuxin Jiang; Ping Liang; Hui-Xiong Xu; Lianfang Du; Yi-Hong Chou; Xiaoyan Xie; YuKun Luo; Young Joon Lee; Jae Young Lee; Bing Hu; Baoming Luo; Yi Wang; Ying Luan; Christina Kalli; Kun Chen; Wenping Wang; Ja-Der Liang
Journal:  Abdom Radiol (NY)       Date:  2021-06-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.